Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac with tramadol, tizanidine, or placebo for acute low back pain
ChiCTR2000039318Phase 4Recruiting
- Sponsor
- Food and Health Bureau
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of diclofenac, tramadol and tizanidine in acute nonspecific low back pain (3 arms), sponsored by Food and Health Bureau. Primary endpoint: RMDQ score at 4 weeks. Started Oct 2020; status: recruiting.
02
Drugs
diclofenactramadoltizanidine
03
Conditions
acute nonspecific low back pain
Beyond the preview
Go deeper on ChiCTR2000039318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039318.